The novelty of the present study is to apply the sensitivity of thyroid hormones indices rather than absolute circulating values of FT3, FT4, and TSH as a predictor of NAFLD risk, which could be more informative, directly correlating thyroid hormone resistance to hepatic metabolic alteration, giving advancement in current knowledge. This evidence concerns the gene TG and metabolic dysfunction-associated steatotic liver disease.